## AMAT: Applied Materials, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 6.7% in lower entry zone (4.0-10.0%), top quartile (84th pct) cross-sectional ranking. Short-term MRS_5 (0.1%) confirms momentum alignment. Outperforming sector by 5.5%. Caution: momentum weakening (-2.4% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($251.73)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Applied Materials stock reaches all-time high at $273.63 USD By Investing.com**
- Source: Investing.com UK | 20251210T201019 | Bullish | Relevance: 100%
- Applied Materials Inc. stock has hit an all-time high of $273.63 USD, demonstrating robust market performance with a 60.44% one-year return and a $216 billion market capitalization. Despite a premium valuation (P/E of 31.4) and some analyst concerns about market share loss, the company maintains a "GREAT" financial health rating and has seen upward revisions to earnings expectations. This success is driven by strategic initiatives and increasing demand in the semiconductor industry.

**2. Applied Materials stock reaches all-time high at $273.63 USD By Investing.com**
- Source: Investing.com Nigeria | 20251210T230807 | Bullish | Relevance: 99%
- Applied Materials (AMAT) stock has hit an all-time high of $273.63 USD, boasting a $216 billion market capitalization and a 60.44% one-year return. Despite a P/E ratio of 31.4 suggesting a premium valuation and some analyst concerns about market share, the company's financial health is rated "GREAT" by InvestingPro, with analysts revising earnings expectations upward.

**3. Applied Materials stock reaches all-time high at $273.63 USD**
- Source: Investing.com | 20251210T195814 | Bullish | Relevance: 98%
- Applied Materials Inc. (AMAT) stock has hit an all-time high of $273.63 USD, boasting a $216 billion market capitalization and a 60.44% one-year return. Despite a premium P/E ratio of 31.4 and appearing slightly overvalued by InvestingPro, the company's "GREAT" financial health and 21 consecutive years of dividend payments, along with recent analyst upgrades, highlight its strong performance in the semiconductor industry.

**4. TD Cowen Lifts Target on Applied Materials (AMAT) to $315, Names It a "Top 2026 Idea"**
- Source: Finviz | 20251210T011014 | Bullish | Relevance: 98%
-  TD Cowen has increased its price target for Applied Materials (AMAT) to $315, maintaining a "Buy" rating and naming it a "Top 2026 Idea." This positive outlook is driven by anticipated structural growth in the DRAM and Foundry segments, fueled by increasing demand for artificial intelligence-related technologies. While acknowledging AMAT's potential, the firm also suggests other AI stocks might offer greater upside with less downside risk.

**5. TD Cowen Lifts Target on Applied Materials (AMAT) to $315, Names It a “Top 2026 Idea”**
- Source: Yahoo Finance | 20251209T220751 | Bullish | Relevance: 98%
-  TD Cowen has increased its price target for Applied Materials (AMAT) to $315 from $260 and maintained a "Buy" rating, designating it a "Top 2026 Idea." This positive outlook is primarily driven by anticipated structural growth in the DRAM and leading-edge Foundry segments, both benefiting from heightened artificial intelligence demand. The firm projects significant growth in non-China DRAM equipment spending and leading-edge Foundry segment, with AMAT well-positioned to capitalize on these trends.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 6, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Keybanc | $285 | $240 | +19% |
| 2025-11-25 | UBS | $285 | $250 | +14% |
| 2025-11-14 | Citigroup | $250 | $205 | +22% |
| 2025-11-14 | Morgan Stanley | $252 | $256 | -2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Keybanc | main | Overweight |
| 2025-11-25 | UBS | up | Buy |
| 2025-11-14 | Citigroup | main | Buy |
| 2025-11-14 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 7 ($28.64M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.6% (-1.1%)
- Blackrock Inc.: 9.3% (-1.2%)
- State Street Corpora: 4.8% (-1.9%)
- Geode Capital Manage: 2.6% (-0.4%)
- Capital Research Glo: 1.9% (+225.4%)

### Key Risks

1. Heavy insider selling: $29M sold (7 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 6 raises (avg +13%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.32 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 36%, ROA 15%, margin 25%). Balance sheet: strong liquidity (2.6x), $2.0B free cash flow. Analyst sentiment positive (6 raises, avg +13%). Insider selling cluster ($28.6M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $215.2B |
| Beta | 1.67 |
| 52W Range | $123.74 - $276.10 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.32 |
| Forward P/E | 23.6 |
| Current P/E | 28.5 |
| YoY Growth | 20.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 9.0% to 6.7% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 84th percentile. MRS_5 at 0.1% confirms short-term momentum alignment. AM_20 at 8.8% shows strong absolute momentum above own 20MA. Outperforming sector by 5.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.86), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.65% (CS: 84) | Strong |
| RSI_14 | 67.0 | Neutral |
| MACD Histogram | 1.86 | Bullish |
| vs SMA20 | 1.088x | Above |
| vs SMA50 | 1.148x | Above |
| vs SMA200 | 1.463x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $270.11
- **Stop Loss:** $251.73 (6.8% risk)
- **Target:** $297.68 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 75
- **Position Value:** $20,258.25
- **Portfolio %:** 20.26%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-12 (Est: $2.20)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.09 | $2.17 | +3.6% |
| 2025Q3 | $2.36 | $2.48 | +5.1% |
| 2025Q2 | $2.31 | $2.39 | +3.5% |
| 2025Q1 | $2.30 | $2.38 | +3.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*